Guru Ownership Trend
Guru Analysis for Alnylam Pharmaceuticals, Inc. (ALNY)
Alnylam Pharmaceuticals, Inc. (ALNY), a key player in the Healthcare sector, continues to attract institutional attention.
As of Q4 2025, a total of 6 Super Investors (Gurus) hold positions in the company, with a combined stake valued at approximately $344.42 M.
Top institutional holders include Cliff Asness and Ray Dalio.
Institutional sentiment is currently Strongly Bullish. This is evidenced by a $94.79 M net inflow during the quarter.
Recent activity highlights Ray Dalio who increased their stake by 152.5%. Conversely, Murray Stahl reduced exposure by 4.2%.
Key Holders
Top 5 by Value
Top 5 by Conviction
Recent Activity Breakdown (Q4 2025)
Guru Consensus (Q4 2025)
FAQs for Alnylam Pharmaceuticals, Inc. (ALNY)
Major holders include Cliff Asness ($365.82 M), Ray Dalio ($34.05 M), Joel Greenblatt ($15.76 M). According to the latest reported data, 6 tracked investment managers collectively hold approximately 1.08 M shares.
According to the latest 13F reporting period, sentiment appears Bullish (Net Buying). There was a net inflow of $94.79 M, with 5 managers increasing positions and 4 managers reducing holdings.
During the most recent reporting period, 1 managers trimmed their positions, while 3 fully exited ALNY. The total reported sell value was $6.7 M.
Yes, 1 managers opened new positions in ALNY, and 4 increased their existing holdings. The total reported buy value was $101.49 M.
